4d pharma (4d pharma) FCF Yield % : -257.13 (As of May. 16, 2024)

View and export this data going back to 2021. Start your Free Trial

What is 4d pharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, 4d pharma's Trailing 12-Month Free Cash Flow is $0.00 Mil, and Market Cap is $0.00 Mil. Therefore, 4d pharma's FCF Yield % for today is -257.13%.

The historical rank and industry rank for 4d pharma's FCF Yield % or its related term are showing as below:

LBPWQ' s FCF Yield % Range Over the Past 10 Years
Min: -260.17 Med: -37.28 Max: -13.65
Current: -257.13

During the past 8 years, the highest FCF Yield % of 4d pharma was -13.65%. The lowest was -260.17%. And the median was -37.28%.

LBPWQ's FCF Yield % is not ranked
in the Biotechnology industry.
Industry Median: -14.305 vs LBPWQ: -257.13

4d pharma's FCF Margin % for the quarter that ended in Dec. 2021 was -3,584.20%.

4d pharma FCF Yield % Historical Data

The historical data trend for 4d pharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4d pharma FCF Yield % Chart

4d pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

FCF Yield %

Get a 7-Day Free Trial

4d pharma Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
FCF Yield %	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of 4d pharma's FCF Yield %

For the Biotechnology subindustry, 4d pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4d pharma's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4d pharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where 4d pharma's FCF Yield % falls into.

4d pharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

4d pharma's FCF Yield % for the fiscal year that ended in Dec. 2021 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-33.624	/
	=	N/A%

4d pharma's annualized FCF Yield % for the quarter that ended in Dec. 2021 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-13.835	*	2	/
	=	N/A%

4d pharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

4d pharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of 4d pharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

4d pharma (4d pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4d pharma PLC (OTCPK:LBPWQ) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Bond Court, Fifth Floor, Leeds, GBR, LS1 2JZ

Website

https://www.4dpharmaplc.com

4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.